Your browser doesn't support javascript.
loading
Anoctamin 2 identified as an autoimmune target in multiple sclerosis.
Ayoglu, Burcu; Mitsios, Nicholas; Kockum, Ingrid; Khademi, Mohsen; Zandian, Arash; Sjöberg, Ronald; Forsström, Björn; Bredenberg, Johan; Lima Bomfim, Izaura; Holmgren, Erik; Grönlund, Hans; Guerreiro-Cacais, André Ortlieb; Abdelmagid, Nada; Uhlén, Mathias; Waterboer, Tim; Alfredsson, Lars; Mulder, Jan; Schwenk, Jochen M; Olsson, Tomas; Nilsson, Peter.
Afiliação
  • Ayoglu B; Affinity Proteomics, Science for Life Laboratory, School of Biotechnology, Royal Institute of Technology (KTH), SE-17165 Stockholm, Sweden; burcu@kth.se.
  • Mitsios N; Affinity Proteomics, Science for Life Laboratory, Department of Neuroscience, Karolinska Institute, SE-17165 Stockholm, Sweden;
  • Kockum I; Neuroimmunology Unit, Department of Clinical Neuroscience, Karolinska Institute, SE-17177 Stockholm, Sweden;
  • Khademi M; Neuroimmunology Unit, Department of Clinical Neuroscience, Karolinska Institute, SE-17177 Stockholm, Sweden;
  • Zandian A; Affinity Proteomics, Science for Life Laboratory, School of Biotechnology, Royal Institute of Technology (KTH), SE-17165 Stockholm, Sweden;
  • Sjöberg R; Affinity Proteomics, Science for Life Laboratory, School of Biotechnology, Royal Institute of Technology (KTH), SE-17165 Stockholm, Sweden;
  • Forsström B; Affinity Proteomics, Science for Life Laboratory, School of Biotechnology, Royal Institute of Technology (KTH), SE-17165 Stockholm, Sweden;
  • Bredenberg J; Affinity Proteomics, Science for Life Laboratory, Department of Neuroscience, Karolinska Institute, SE-17165 Stockholm, Sweden;
  • Lima Bomfim I; Neuroimmunology Unit, Department of Clinical Neuroscience, Karolinska Institute, SE-17177 Stockholm, Sweden;
  • Holmgren E; Therapeutic Immune Design Unit, Department of Clinical Neuroscience, Karolinska Institute, SE-17177 Stockholm, Sweden;
  • Grönlund H; Therapeutic Immune Design Unit, Department of Clinical Neuroscience, Karolinska Institute, SE-17177 Stockholm, Sweden;
  • Guerreiro-Cacais AO; Neuroimmunology Unit, Department of Clinical Neuroscience, Karolinska Institute, SE-17177 Stockholm, Sweden;
  • Abdelmagid N; Neuroimmunology Unit, Department of Clinical Neuroscience, Karolinska Institute, SE-17177 Stockholm, Sweden;
  • Uhlén M; Affinity Proteomics, Science for Life Laboratory, School of Biotechnology, Royal Institute of Technology (KTH), SE-17165 Stockholm, Sweden;
  • Waterboer T; Infection and Cancer Program, German Cancer Research Center, 69120 Heidelberg, Germany;
  • Alfredsson L; Institute of Environmental Medicine, Karolinska Institute, SE-17177 Stockholm, Sweden; Centre for Occupational and Environmental Medicine, Stockholm County Council, SE-11365 Stockholm, Sweden.
  • Mulder J; Affinity Proteomics, Science for Life Laboratory, Department of Neuroscience, Karolinska Institute, SE-17165 Stockholm, Sweden;
  • Schwenk JM; Affinity Proteomics, Science for Life Laboratory, School of Biotechnology, Royal Institute of Technology (KTH), SE-17165 Stockholm, Sweden;
  • Olsson T; Neuroimmunology Unit, Department of Clinical Neuroscience, Karolinska Institute, SE-17177 Stockholm, Sweden;
  • Nilsson P; Affinity Proteomics, Science for Life Laboratory, School of Biotechnology, Royal Institute of Technology (KTH), SE-17165 Stockholm, Sweden;
Proc Natl Acad Sci U S A ; 113(8): 2188-93, 2016 Feb 23.
Article em En | MEDLINE | ID: mdl-26862169
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Autoanticorpos / Canais de Cloreto / Proteínas de Membrana / Esclerose Múltipla Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Autoanticorpos / Canais de Cloreto / Proteínas de Membrana / Esclerose Múltipla Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2016 Tipo de documento: Article